Swiss - Delayed Quote CHF
Basilea Pharmaceutica AG (BSLN.SW)
44.45
+0.55
+(1.25%)
At close: May 7 at 5:31:11 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
74,363
74,363
14,245
7,056
-32,020
Investing Cash Flow
-1,011
-1,011
-1,034
91,649
3,575
Financing Cash Flow
-13,164
-13,164
-57,305
-45,246
16,640
End Cash Position
124,560
124,560
64,322
108,567
54,953
Capital Expenditure
-1,792
-1,792
-1,034
-3,303
-860
Issuance of Capital Stock
2,439
2,439
2,390
4,426
44,106
Issuance of Debt
--
--
0
73,875
0
Repayment of Debt
-15,603
-15,603
-59,314
0
-23,212
Repurchase of Capital Stock
0
0
-381
--
-4,254
Free Cash Flow
72,571
72,571
13,211
3,753
-32,880
12/31/2021 - 3/25/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.SG ImmuPharma PLC
0.0300
-1.64%
328.SG MeiraGTx Holdings PLC
4.7800
-4.02%
BT3.BE Lineage Cell Therapeutics Inc
0.3740
-5.08%
SCP.F Scancell Holdings plc
0.0960
+12.28%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
GNFTF Genfit S.A.
3.5400
0.00%
6XC.F Soleno Therapeutics, Inc.
62.25
-2.51%
22Z.SG Zealand Pharma A/S
60.20
-5.97%
AYJ.HA Valneva SE
2.9080
+0.28%
VSC.F 4SC AG
2.5000
0.00%